Physician profile
Dario Martinez
NPI 1174800148
$893.89
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $243 · 2020: $182 · 2021: $125 · 2022: $44.07 · 2023: $109 · 2024: $191.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $299.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $152.06 | 2020 | |
| Gilead Sciences, INC. | $142.61 | 2019-2024 | |
| Boston Scientific Corporation | $133.71 | 2022-2024 | Watchman Flx |
| Amgen INC. | $124.99 | 2021 | |
| Ethicon US, LLC | $118.44 | 2019 | |
| Abbvie INC. | $86.41 | 2023-2024 | |
| Novartis Pharmaceuticals Corporation | $35.38 | 2023-2024 | |
| Janssen Pharmaceuticals, INC | $29.52 | 2020 | |
| Daiichi Sankyo INC. | $26.44 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $25.00 | 2024 | Xifaxan |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $19.33 | 2024 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dario Martinez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.